Benzinga | Dec 3, 2021 09:57AM EST

Alliance Global Partners Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $5.75

Alliance Global Partners initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $5.75.